[1]
Vinay, N. and David, D.C. 2019. Evaluation and comparison of anti-cancer activity of dapagliflozin and canagliflozin in oral cancer cell line: an in vitro study. International Journal of Basic & Clinical Pharmacology. 8, 3 (Feb. 2019), 473–477. DOI:https://doi.org/10.18203/2319-2003.ijbcp20190459.